A newly published study from a Dutch research group has suggested that higher muscle mass is associated with less risk for fatigue in men with advanced prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: exercise, fatigue, mass, muscle | Leave a comment »
For many years now, The “New” Prostate Cancer InfoLink has argued (on the basis of no good data at all) that starting to do Kegel exercises prior to having surgery for prostate cancer was likely to be able to accelerate recovery of good continence after one’s surgery. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: exercise, floor, Kegel, muscle, pelvic, surgery, timing | 1 Comment »
Data from early Phase I/II clinical trials of abiraterone acetate in men with metastatic, castration-resistant prostate cancer (mCRPC) suggest that combining abiraterone acetate with dexamethasone limits loss of muscle mass and visceral fat. Low-dose dexamethasone was used rather than prednisone in these early clinical trials. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abiraterone, dexamethasone, fat, muscle, quality of life | Leave a comment »
Unsurprisingly, according to a new article in the Journal of Clinical Oncology, long-term androgen deprivation therapy (ADT) is closely associated with loss of lean muscle mass (known as sarcopenia) in men being treated for prostate cancer. However, this appears to be the first time anyone has shown there is an age-related factor that is relevant to the degree of loss of lean muscle. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: ADT, androgen deprivation, lean, loss, mass, muscle | 4 Comments »
